Milestone Pharmaceuticals (MIST)
NASDAQ:MIST
US Market
Holding MIST?
Track your performance easily

Milestone Pharmaceuticals (MIST) Financial Statements

448 Followers

Milestone Pharmaceuticals Financial Overview

Milestone Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.105; its P/E ratio is -1.31; Milestone Pharmaceuticals is scheduled to report earnings on November 13, 2024, and the estimated EPS forecast is $-0.16. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -8.48M$ -6.60M$ -2.76M$ -5.42M$ -8.48M
EBITDA$ -8.45M$ -6.58M$ -2.74M$ -5.34M$ -8.38M
Net Income Common Stockholders$ -9.36M$ -10.35M$ -33.88M$ -6.26M$ -16.04M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 83.25M$ 89.48M$ 65.96M$ 75.75M$ 87.59M
Total Assets$ 89.23M$ 96.00M$ 75.23M$ 87.12M$ 97.02M
Total Debt$ 53.25M$ 52.51M$ 51.77M$ 51.03M$ 50.32M
Net Debt$ -30.00M$ -36.98M$ -14.19M$ -24.72M$ -37.27M
Total Liabilities$ 57.25M$ 56.08M$ 58.45M$ 58.61M$ 56.61M
Stockholders Equity$ 32.02M$ 39.92M$ 16.77M$ 28.50M$ 40.44M
Cash Flow-
Free Cash Flow$ -6.06M$ -8.93M$ -9.83M$ -12.18M$ -10.60M
Operating Cash Flow$ -6.05M$ -8.93M$ -9.80M$ -12.16M$ -10.56M
Investing Cash Flow$ 9.48M$ -27.01M$ 13.68M$ -10.86M$ -28.03M
Financing Cash Flow$ -298.00K$ 32.32M$ 1.00K$ 305.00K$ -2.77M
Currency in USD

Milestone Pharmaceuticals Earnings and Revenue History

Milestone Pharmaceuticals Debt to Assets

Milestone Pharmaceuticals Cash Flow

Milestone Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis